CIK 0001635088 · Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- operating
- EIN
- 981173944
- Phone
- 441-295-5950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- CERT Other Certification
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Other events
- 8-A12B/A Other Registration Statement
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-A12B Other Registration of Securities
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- S-4/A Deal Registration Statement - Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Insider Changes in Ownership
- 425 Deal Prospectus/Communication re Business Combination
- SC 13D/A Stake Beneficial Ownership Report
Page 46 of 51 · 1,008 filings